NASDAQ:MEIP MEI Pharma - MEIP News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding MEI Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.31 -0.02 (-6.08%) (As of 01/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.31▼$0.3250-Day Range$0.22▼$0.4152-Week Range$0.21▼$2.21Volume483,419 shsAverage Volume507,347 shsMarket Capitalization$41.20 millionP/E RatioN/ADividend YieldN/APrice Target$2.86 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Get MEI Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter. Email Address MEIP Media Mentions By Week MEIP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MEIP News Sentiment▼0.220.71▲Average Medical News Sentiment MEIP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MEIP Articles This Week▼31▲MEIP Articles Average Week All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMEI Pharma, Inc. (NASDAQ:MEIP) Given Average Recommendation of "Hold" by Analystsamericanbankingnews.com - January 24 at 3:18 AMMEI Pharma (NASDAQ:MEIP) Now Covered by StockNews.comamericanbankingnews.com - January 21 at 6:39 AMMEI Pharma slumps on ending lead drug development ex-Japan, analysts downgrade stockseekingalpha.com - December 6 at 4:46 PMMEI Pharma Announces Adjournment of Annual Meeting of Stockholdersfinance.yahoo.com - December 6 at 4:46 PMMEI Pharma Shares Dive 34% on Discontinued Development of Zandelisib Outside of Japanmarketwatch.com - December 6 at 3:17 AMMEI Pharma Initiates Strategic Realignmentfinance.yahoo.com - December 5 at 10:00 PMMEI Pharma First Quarter 2023 Earnings: Beats Expectationsfinance.yahoo.com - November 20 at 9:05 AMAnalysts Just Published A Bright New Outlook For MEI Pharma, Inc.'s (NASDAQ:MEIP)finance.yahoo.com - November 19 at 6:03 PMKyowa Kirin and MEI Pharma Announce Topline Data from the Phase 2 MIRAGE Study Evaluating Zandelisib in Patients with Indolent B-cell non-Hodgkin’s Lymphoma in Japanfinance.yahoo.com - November 18 at 2:34 PMMEI Pharma Reports First Quarter Fiscal Year 2023 Results and Operational Highlightsfinance.yahoo.com - November 15 at 10:14 AMMEI Pharma, Inc. (MEIP) Reports Q1 Loss, Lags Revenue Estimatesfinance.yahoo.com - November 15 at 10:14 AMWe're Keeping An Eye On MEI Pharma's (NASDAQ:MEIP) Cash Burn Ratefinance.yahoo.com - November 7 at 7:55 PMMEI Pharma and Kyowa Kirin Announce Acceptance of Three Abstracts for Presentation at the American Society of Hematology Annual Meeting 2022finance.yahoo.com - November 3 at 11:24 AMMEI Pharma, Inc. (MEIP)au.finance.yahoo.com - September 25 at 12:01 AMMEI Pharma Announces Changes to Board of Directorsfinance.yahoo.com - September 22 at 1:03 PM1MEIP : Looking Into MEI Pharma's Return On Capital Employedbenzinga.com - September 17 at 1:30 PMMEI Pharma stock trades higher as FY22 revenue grows 17%seekingalpha.com - September 9 at 11:22 AMEdited Transcript of MEIP.OQ earnings conference call or presentation 8-Sep-22 9:00pm GMTfinance.yahoo.com - September 9 at 6:21 AMMEI Pharma, Inc. (MEIP) Q4 2022 Earnings Call Transcriptseekingalpha.com - September 9 at 1:20 AMMEI Pharma Reports Fiscal Year 2022 Results and Operational Highlightsfinance.yahoo.com - September 8 at 8:20 PM1MEIP : Earnings Outlook For MEI Pharmamsn.com - September 7 at 6:58 PMMEI Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022finance.yahoo.com - September 6 at 8:52 AMMEI Pharma to Release 2022 Fiscal Year End Financial Results and Provide Corporate Update on September 8, 2022finance.yahoo.com - September 1 at 11:44 AMGreenWood Investors Second Quarter 2022 Letterseekingalpha.com - August 25 at 12:25 AMShareholders in MEI Pharma (NASDAQ:MEIP) are in the red if they invested a year agonasdaq.com - August 19 at 8:26 PMMEI Pharma (NASDAQ:MEIP) investors are sitting on a loss of 79% if they invested a year agofinance.yahoo.com - August 18 at 2:23 PMMEI Pharma and Kyowa Kirin Announce Publication in The Lancet Oncology of Data from Phase 1b Clinical Study of Zandelisib in Patients with Relapsed or Refractory B-cell Malignancyfinance.yahoo.com - July 18 at 8:15 AMMEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | Morningstarmorningstar.com - July 3 at 3:36 AMMEI Pharma Appoints Human Resources Executive Anne Frese as Chief People Officerfinance.yahoo.com - June 22 at 1:14 PMMEI Pharma Reports Third Quarter Fiscal Year 2022 Results and Operational Highlightsfinance.yahoo.com - May 23 at 7:12 PMMEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimatesfinance.yahoo.com - May 23 at 7:12 PMINVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in MEI Pharma, Inc. with Losses of $100,000 to Contact the Firmapnews.com - May 18 at 7:13 AMMEI Pharma to Present at the H.C. Wainwright Global Investment Conference 2022finance.yahoo.com - May 17 at 11:11 AMINVESTIGATION ALERT: The Schall Law Firm Encourages Investors in MEI Pharma, Inc. with Losses of $100,000 to Contact the Firmapnews.com - May 17 at 1:11 AMThe Law Offices of Frank R. Cruz Announces Investigation of MEI Pharma, Inc. (MEIP) on Behalf of Investorsapnews.com - May 17 at 1:11 AMWe're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Ratefinance.yahoo.com - May 12 at 5:22 PMMEI Pharma and Kyowa Kirin Announce Acceptance of Two Abstracts for Presentation at the European Hematology Association 2022 Hybrid Congressfinance.yahoo.com - May 12 at 12:21 PMPacira (PCRX) Q1 Earnings Miss Estimatesfinance.yahoo.com - May 4 at 1:30 PMMEI Pharma Announces Two Presentations at the American Association for Cancer Research Annual Meeting 2022finance.yahoo.com - April 8 at 5:21 PMRevenue Downgrade: Here's What Analysts Forecast For MEI Pharma, Inc. (NASDAQ:MEIP)finance.yahoo.com - March 28 at 10:22 PMAnalyzing Mei Pharma Inc's Short Interestmsn.com - March 28 at 5:22 PM"Near-Term Zandelisib Launch off the Table" After "Bewildering" FDA Feedback – MEI Pharma (MEIP) Stock Crashes as Analysts Downgrades Roll Ininvesting.com - March 25 at 6:13 PMExpert Ratings For MEI Pharmamarkets.businessinsider.com - March 25 at 6:13 PMAnalysts Cut Price Target On MEI Pharma As Stock Falls To 52-Week Low After Zandelisib Updatefinance.yahoo.com - March 25 at 6:13 PMMEI Pharma falls on setback to U.S. marketing application for lymphoma therapyseekingalpha.com - March 25 at 8:43 AMWhy MEI Pharma Stock Is Plummeting After Hoursmsn.com - March 24 at 5:41 PMMEI Pharma and Kyowa Kirin Provide Regulatory Update on Zandelisib Following Meeting with the FDAfinance.yahoo.com - March 24 at 5:41 PMMEI Pharma Announces Acceptance of Two Abstracts for Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022finance.yahoo.com - March 8 at 8:52 PMAnalyst Forecasts Just Became More Bearish On MEI Pharma, Inc. (NASDAQ:MEIP)finance.yahoo.com - February 12 at 9:45 AMMEI Pharma Reports Second Quarter Fiscal Year 2022 Results and Operational Highlightsfinance.yahoo.com - February 10 at 5:10 PM Get MEI Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:MEIP) was last updated on 1/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.